| Author (Year) | Patient | Site of Thrombus | Timing of Thrombus | Treatment Regimen |
|---|---|---|---|---|
| Hazani A, et al. (1988) | 11M | CVST | Diagnosis | N/A |
| Torromeo C, et al. (2001) | 50M | IVT | Induction | ATRA + idarubicin |
| Torromeo C, et al. (2001) | 32F | IVT | Induction | ATRA + idarubicin |
| Dally N, et al. (2005) | ‐‐ | CVST | Induction | ATRA + daunorubicin |
| Dally N, et al. (2005) | ‐‐ | CVST | Induction | ATRA + daunorubicin |
| Breccia M, et al. (2007) | 32F | IVT | Induction | ATRA + idarubicin |
| Breccia M, et al. (2007) | 50M | IVT | Induction | ATRA + idarubicin |
| Ciccone M, et al. (2008) | 35F | CVST | Remission | ATRA + idarubicin |
| Beslow LA, et al. (2009) | 12M | CVST | Diagnosis | N/A |
| Kayal S, et al. (2011) | 3F | IVT | Induction | ATRA + daunomycin |
| Lee KR, et al. (2014) | 22F | CVST | Induction | ATRA + idarubicin |
| Song LX, et al. (2014) | 28F | CVST | Induction | ATRA |
| Ashwath, et al. (2021) | 28F | CVST + IVT | Induction | ATRA + arsenic trioxide |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.